Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11526 posts found.

european_commission_web

European green light for Lynparza in germline BRCA-mutated metastatic pancreatic cancer

July 8, 2020 Research and Development, Sales and Marketing AstraZeneca, Cancer, Europe, MSD, lynparza

The European Commission has awarded approval to AstraZeneca and MSD’s Lynparza (olaparib) for germline BRCA-mutated (gBRCAm) metastatic pancreatic cancer, with …
News
3018710552_f8cebf1dab_c

Tesla to offer “microfactories” to scale up production of CureVac’s potential COVID-19 vaccine

July 6, 2020 Manufacturing and Production, Sales and Marketing COVID-19, CureVac, Vaccine, tesla

Electric car firm Tesla has announced it will be supplying mobile molecular printer capacity to German firm CureVac, and possibly …
News
viiv

ViiV Healthcare secures FDA approval for Rukobia combo in multidrug-resistant HIV-1

July 6, 2020 Sales and Marketing FDA, HIV, ViiV Healthcare

ViiV Healthcare, the HIV specialist majority owned by GSK which also counts Shionogi and Pfizer among its shareholders, has secured …
News
remsssy

US moving remdesivir supplies to COVID-19 hotspots

July 6, 2020 Sales and Marketing Arizona, COVID, states, texas

The US government is sending significant remdesivir supplies to states that are being hit hardest by the coronavirus. Florida, Arizona …
News
amoeba

Florida issues warning over ‘brain-eating’ amoeba

July 6, 2020 Sales and Marketing amoeba, infection, lakes

The Florida Department of Health has issued a warning over a rare case of ‘brain-eating’ amoeba after one person has …
News
who_flag

WHO halt coronavirus trials of hydroxychloroquine, lopinavir and ritonavir

July 6, 2020 Sales and Marketing COVID, COVID-19, WHO, coronavirus

The World Health Organization has discontinued trials into the viability of hydroxychloroquine, lopinavir and ritonavir as COVID-19 treatments. This was …
News
top_10_image_2_1

Top Ten most popular articles on Pharmafile.com this week

July 3, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, coronaviurs, top 10

Gilead features prominently in the news this week, as the US bought most of the world’s stock of the company’s …
News
leicester_copyright_mat_fascione

UK Government accused of withholding Pillar 2 COVID-19 data which show Leicester had 10 times more cases than reported pre-lockdown

July 1, 2020 Medical Communications, Research and Development, Sales and Marketing COVID-19, UK

The UK Government warned when relaxing lockdown measures on 23 June that it would not hesitate to lock down any …
News

FDA approves Pfizer and Merck KGaA’s Bavencio for maintenance of advanced bladder cancer

July 1, 2020 Research and Development, Sales and Marketing Bavencio FDA, EMD Serono, Merck, Pfier

The FDA has moved to approve Bavencio (avelumab), developed by Pfizer and EMD Serono, the biopharma arm of Merck KGaA, …
News
roche

Roche’s Phesgo combo secures US approval for metastatic HER2-positive breast cancer

June 30, 2020 Manufacturing and Production, Sales and Marketing FDA, Phesgo, Roche, US, breast cancer

The FDA has awarded marketing authorisation in the US to Roche’s Phesgo, a combination of subcutaneously injected Herceptin (trastuzumab) with …
News
pharmafocus_july-august_2020_cover

The July/August 2020 issue of Pharmafocus is available to read free online now!

June 30, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, Pharmafocus, pharma

The July/August 2020 issue of Pharmafocus is available to read free online now!
News

NICE knocks back Janssen’s Zytiga combo for newly diagnosed, hormone-sensitive metastatic prostate cancer.

June 29, 2020 Sales and Marketing

Drug watchdog NICE has chosen to stick with its earlier decision not to recommend Janssen’s Zytiga (abiraterone aetate), combined with …
News
fdaoutsideweb

FDA rejects Allergan’s Abicipar pegol for neovascular age-related macular degeneration over benefit/risk concerns

June 29, 2020 Sales and Marketing AbbVie, Allergan, FDA, pharma

The FDA has moved to reject Allergan’s vascular endothelial growth factor (VEGF) factor A inhibitor, Abicipar pegol, as treatment for …
News

Vaxart announces its COVID-19 vaccine has been selected by US Operation Warp Speed programme

June 29, 2020 Sales and Marketing COVID-19, COVID-19 vaccine, coronavirus, coronavirus vaccine

Vaxart has announced the selection of its lead vaccine candidate for COVID-19 by Operation Warp Speed, a program to find …
News
chinese_army

China’s COVID-19 vaccine candidate approved for military use

June 29, 2020 Sales and Marketing COVID-19, coronavirus

China’s military have received approval to use a new vaccine candidate for coronavirus after clinical trials proved it was safe …
News
The Gateway to Local Adoption Series

Latest content

Sandoz launches allergy relief nasal spray in Germany and Switzerland

April 9, 2026

Japan approve Daiichi Sankyo’s Enhertu as a second-line treatment for gastric cancer

April 9, 2026

Trelleborg to take part in Medtec Japan 2026

April 8, 2026

Kainova Therapeutics expands phase I/II trial of antibody drug

April 7, 2026

Eisai starts enrolment for phase 2 narcolepsy study evaluating E2086

April 7, 2026